Both are important in the weight loss conversation, but they are different
When it comes down to it, pricing often reflects the pharmacy, the dose, and whats included in the program or service
When weight loss has plateaued for four weeks or more at a stable dose, hunger is returning noticeably between injections, or food noise is picking back up
Earlier initiation is reshaping patient journeys: Patients are starting GLP1 therapy within weeks of diagnosis, underscoring the need for streamlined access pathways and payer alignment to reduce delays, especially in Medicare populations
Whether that reflects a strategic choice, a technical dead end with oral tirzepatide, or simply a faster path to market isnt publicly knownbut for now, orforglipron is the oral option Lilly is bringing forward